Company Profile
Entering Ruichen Kangda Biomedical (Wuhan) Co., Ltd.
Ruichen Kangda Biopharmaceutical (Wuhan) Co., Ltd. was registered and established in August 2018 in Donghu High tech Development Zone, Wuhan. The company has a strong R&D team led by several senior overseas returnees and PhDs. The core team mostly has many years of work experience in large pharmaceutical R&D enterprises and has mature drug development and marketing capabilities.
The company focuses on the synthesis of innovative drug intermediates, process development and synthesis of high-end generic drug raw materials, and synthesis of functional new materials. Adhering to the core concept based on synthetic chemistry, we are committed to developing new processes and methods, building products in a green and efficient manner, and solving the problems of product accessibility from 0 to 1 and efficient product acquisition from 1 to 100. At present, the company relies on its strong chemical synthesis capabilities and conducts research and development of new processes and methods to achieve efficient synthesis of differentiated products at a greener and lower cost, breaking the existing technological monopoly and better meeting market demand. Therefore, the large-scale production of multiple products has been successfully completed. In addition, based on common technologies, the company has successfully developed multiple independently initiated projects such as polysaccharide drugs, metal sugar complexes, and solubilization degradable materials, with extremely broad market prospects.
Ruichen Kangda Biopharmaceutical (Wuhan) Co., Ltd. will continuously explore and advance in the field of biomedicine with its strong research and innovation capabilities, contribute to the development of the industry, and create more value for human health.
Enterprise culture
Corporate Vision:
Become the industry leader in the segment of fine chemical manufacturers.
Enterprise Mission:
Starting from the end, we have a deep understanding of customers, products and quality,
Empowering the pharmaceutical industry with chemistry
Values:
Focus, innovation, win-win
Honor
High-tech enterprise certificate
Green Leaf Starlifer Program - Excellent star
Enterprise honor certificate
Won the "Little Giant" of Wuhan Science and Technology in 2020
Won the high-tech enterprise in 2020
Won the national science and technology small and medium-sized enterprise in 2021
Won 3551 Optical Valley Talent in 2021
Talent team
Ruichen Kangda Biopharmaceutical (Wuhan) Co., Ltd. was registered and established in Wuhan East Lake National Independent Innovation Demonstration Zone East Lake High-tech Development Zone in August 2018. The company has a high-quality and high-level R & D team led by a number of senior overseas returnees.
SAF Coolest v1.3 设置面板 GAGSD-ZGYF-JSZDE-ZXQ
无数据提示
Sorry, the current column has no content for the time being.!
You can view other columns or returnHome Page